These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6453419)

  • 1. Correlation between suppression of B cell anti-hapten response and generation of cytotoxic T cells induced by hapten-labelled syngeneic lymphocytes.
    Ramos T; Möller E
    Scand J Immunol; 1981; 13(2):119-25. PubMed ID: 6453419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T cell responses to haptenated cells. I. Primary, secondary and long-term cultures.
    Pohlit H; Haas W; von Boehmer H
    Eur J Immunol; 1979 Sep; 9(9):681-90. PubMed ID: 315877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface structures required for B-cell activation with haptenated syngeneic cells.
    Ramos T
    Scand J Immunol; 1983 May; 17(5):411-7. PubMed ID: 6407098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The donor cell type controls anti-hapten (fluorescein isothiocyanate) primary antibody response to hapten-modified syngeneic cells.
    Suzuki K; Nakashima I; Takashi M; Nagase F; Kato N; Isobe K; Mizoguchi K; Saito M
    Immunol Lett; 1982 Oct; 5(4):217-21. PubMed ID: 6816722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo sensitization of T cells to hapten-conjugated syngeneic structures of major histocompatibility complex. I. Effect of in vitro culture upon generation of cytotoxic T lymphocytes.
    Starzinski-Powitz A; Pfizenmaier K; Röllinghoff M; Wagner H
    Eur J Immunol; 1976 Nov; 6(11):799-805. PubMed ID: 1087237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to haptenated syngeneic and allogeneic lymphocytes. I. Restrictions for B cell activation by haptenated lymphocytes and specificity of the antibodies generated.
    Ramos T; Möller G
    Scand J Immunol; 1978; 8(1):1-7. PubMed ID: 360369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral tolerance induced in lymph nodes by syngeneic spleen cells inhibits generation of CTLs to hapten-altered self antigens but not to alloantigens.
    Matriano JA; Battisto JR
    Cell Immunol; 1991 Aug; 136(1):16-28. PubMed ID: 1829397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
    Moser G; Burakoff SJ; Abbas AK
    J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction in vivo between hapten-specific suppressor T cells and an in vitro cultured helper T cell line.
    Owens T; Miller JF
    J Immunol; 1987 Mar; 138(6):1687-92. PubMed ID: 2950167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo regulation of the primary response of cytolytic T cells to hapten-altered self antigens by an inducible suppressor T cell.
    Battisto JR; Wong HL
    Ann N Y Acad Sci; 1982; 392():144-55. PubMed ID: 6215876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-H-2-associated genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. Effect on the magnitude of secondary response and helper T cell generation after in vivo priming.
    Fujiwara H; Shearer GM
    Eur J Immunol; 1981 Sep; 11(9):700-4. PubMed ID: 6975212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses.
    Herzenberg LA; Tokuhisa T
    J Exp Med; 1982 Jun; 155(6):1730-40. PubMed ID: 6176665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct suppressor T cells acting in concert cause suppression of cytolytic T lymphocyte (CTL) response to hapten-altered self in vivo.
    Gautam SC; Beckman KD; Wong HL; Battisto JR
    J Immunol; 1983 Jun; 130(6):2557-60. PubMed ID: 6222107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of self-carriers in the immune response and tolerance. I. B-cell unresponsiveness and cytotoxic T-cell immunity induced by haptenated syngeneic lymphoid cells.
    Scott DW; Long CA
    J Exp Med; 1976 Nov; 144(5):1369-74. PubMed ID: 1086885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF; Nossal GJ
    J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary antibody responses to hapten-modified syngeneic cells: exceptional immunogenicity of erythrocytes.
    Nakashima I; Takashi M; Nagase F; Kato N
    Eur J Immunol; 1981 Nov; 11(11):946-8. PubMed ID: 6799301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two suppressor cells that together prevent in vivo development of cytolytic T cells to hapten-altered self.
    Gautam SC; Beckman KD; Wong HL; Battisto JR
    Cell Immunol; 1984 Aug; 87(1):23-34. PubMed ID: 6234995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.